HC Wainwright & Co. Reiterates Buy on Asensus Surgical, Maintains $2 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a 'Buy' rating on Asensus Surgical (AMEX:ASXC) and maintained a $2 price target.
August 11, 2023 | 10:46 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Asensus Surgical's stock has been reiterated as a 'Buy' by HC Wainwright & Co. with a maintained price target of $2.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for Asensus Surgical. The maintained price target of $2 also indicates the firm's confidence in the stock's potential. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100